Loading...
Loading...
Indian Pharmaceutical Exporter Β· #4 for Bleomycin Β· $290.8K export value Β· DGFT Verified
NV Remedies Private Limited is the #4 Indian exporter of Bleomycin with $290.8K in export value and 12 verified shipments. NV Remedies Private Limited holds a 5.2% market share in Bleomycin exports across 3 countries. The company exports 15 pharmaceutical products worth $4.8M across 4 therapeutic categories.

| Country | Value | Shipments | Share |
|---|---|---|---|
| UKRAINE | $149.4K | 10 | 74.6% |
| CONGO | $50.0K | 1 | 24.9% |
| KYRGHYSTAN | $983 | 1 | 0.5% |
NV Remedies Private Limited exports Bleomycin to 3 countries. The largest destination is UKRAINE accounting for 74.6% of NV Remedies Private Limited's Bleomycin shipments, followed by CONGO (24.9%) and KYRGHYSTAN (0.5%). These destinations reflect NV Remedies Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CPC "BIOCON" LLC | UKRAINE | $149.4K | 7 |
| CENTRE NATIONAL DE LUTTE CONTRE | CONGO | $50.0K | 1 |
| KYRGYZPHARMACY | KYRGHYSTAN | $983 | 1 |
| MILI HEALTHCARE LTD | UKRAINE | $2 | 2 |
| MILI HEALTHCARE LIMITED | UKRAINE | $2 | 1 |
NV Remedies Private Limited supplies Bleomycin to 5 buyers globally. The largest buyer is CPC "BIOCON" LLC (UKRAINE), followed by CENTRE NATIONAL DE LUTTE CONTRE (CONGO) and KYRGYZPHARMACY (KYRGHYSTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $3.6M worth of Bleomycin through 1,101 shipments from 206 suppliers to 119 countries, serving 426 buyers globally. NV Remedies Private Limited contributes $290.8K to this total, accounting for 5.2% of India's Bleomycin exports. NV Remedies Private Limited ships Bleomycin to 3 countries through 5 buyers.
NV Remedies Private Limited's average Bleomycin shipment value is $24.2K per consignment, based on 12 shipments totaling $290.8K. The largest destination is UKRAINE (74.6% of NV Remedies Private Limited's Bleomycin exports).
NV Remedies Private Limited ranks #4 among 206 Indian Bleomycin exporters with a 5.2% market share. The top 3 exporters are VENUS REMEDIES LIMITED ($1.2M), NAPROD LIFE SCIENCES PRIVATE LIMITED ($485.6K), INFUGEN PHARMA PRIVATE LIMITED ($300.0K). NV Remedies Private Limited processed 12 shipments to 3 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| BLEOMYCIN-MILI BLEOMYCIN FOR INJ USP E.V | $50.0K | 1 |
| BLEOMYCIN FOR INJECTION USP EACH VIAL CO | $50.0K | 1 |
| BLEOMYCIN FOR INJECTION (15 IU) EACH VIAL CONTAINS: BLEOMYCIN SULPHATE EQUIVALENT TO BLEOMYCIN... 15 IU (BLEONCO15 IU) | $50.0K | 1 |
| BLEOMYCIN FOR INJECTION 15 IU E.VL.C. BLEOMYCIN SULPHATE EQ.TO BLEOMYCIN..15 IU(BLEONCO ) B.NO.X4FBL011A | $49.3K | 1 |
| BLEOMYCIN-MILI LYOPHILIZATE FOR SOLUTIONFOR INJ.BLEOMYCIN FOR INJ.USP 15 UNITSBNO :X3LBL011I MDT :12/2023 ED.11/2025 | $983 | 1 |
| BLEOMYCIN SULFATE USP WORKING STANDARD N | $147 | 4 |
| BLEOMYCIN SULFATE USP WORKING STANDARD WORKINGSTANDARDNO:WS/01/23/BLEMFG.DT:06/06/2023VALIDUPTO:05/12/2024 | $2 | 1 |
| BLEOMYCIN SULFATE USP WORKING STANDARD WORKING STANDARD NO : WS/01/24/BLE MFG. DT : 04/12/2024 VALID UPTO : 03/06/2026 |
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $485.6K | 13 | 7 | $37.4K |
| 3 | INFUGEN PHARMA PRIVATE LIMITED | $300.0K | 6 | 1 | $50.0K |
| 4 | NV REMEDIES PRIVATE LIMITED β | $290.8K | 12 | 3 | $24.2K |
| 6 | SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED | $273.1K | 6 | 2 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 288 | 26.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 248 | 22.5% |
| DELHI AIR CARGO ACC (INDEL4) | 171 | 15.5% |
| DELHI AIR | 124 | 11.3% |
| Bombay Air | 70 | 6.4% |
| Delhi Air | 29 | 2.6% |
| Bombay Air Cargo | 24 | 2.2% |
| Delhi Air Cargo | 14 | 1.3% |
NV Remedies Private Limited also exports these advanced oncology products. Each links to the detailed product page.
NV Remedies Private Limited exports 15 products worth $4.8M. Beyond Bleomycin, top products include Docetaxel, Oxaliplatin, Carboplatin, Paclitaxel, Chlorpheniramine. View the complete NV Remedies Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Bleomycin β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for NV Remedies Private Limited's Bleomycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NV Remedies Private Limited
Full Company Profile β
15 products Β· $4.8M total trade Β· 4 categories
| $2 |
| 1 |
| BLEOMYCIN SULFATE USP REFERENCE STANDARDUSP LOT NO. R118Q1 | $1 | 1 |
NV Remedies Private Limited exports 9 distinct Bleomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BLEOMYCIN-MILI BLEOMYCIN FOR INJ USP E.V with 1 shipments worth $50.0K.
| $45.5K |
| 7 | CIPLA LIMITED | $250.0K | 5 | 2 | $50.0K |
NV Remedies Private Limited ranks #4 among 206 Indian Bleomycin exporters. Average shipment value of $24.2K compared to the market average of $17.6K. The closest competitors by value are NAPROD LIFE SCIENCES PRIVATE LIMITED and INFUGEN PHARMA PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 426+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for NV Remedies Private Limited.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bleomycin. For current shipment-level data, contact TransData Nexus.